In this work, the synthesis of 55 tricarbonylmethane derivatives from dimedone, cyclohexane1,3-dione, indandione, and Meldrum’s acid using three complementary strategies is reported. In total, 10 α-hydroxymethylene-1,3-diones, 40 α-aryl/alkylaminomethylene-1,3-cycloalkanediones, and 5 dihydroquinazolin-5(6H)-ones were prepared, including 20 compounds described herein for the first time. Several members of these three families display relevant biological activities, including herbicidal activity (α-hydroxymethylene-1,3-diones), electron transport chain inhibition (α-aryl/alkylaminomethylene-1,3-cycloalkanediones), and inhibition of NADPH (nicotinamide adenine dinucleotide phosphate) production (dihydroquinazolin-5(6H)-ones). Particular attention was given to α-hydroxymethylene-1,3-diones as broad-spectrum intermediates, whose reactivity enabled access to α-aryl/alkylaminomethylene-1,3-cycloalkanediones and dihydroquinazolinones, highlighting their potential as entry points for diversity-oriented synthesis (DOS). The observed reactivity patterns suggest structural factors such as tricarbonylmethane acidity, tricarbonylmethane electrophilicity, nucleophile basicity, and steric hindrance effects control the reactions outcomes. Usually, DMF-DMA (N,N-dimethylformamide dimethyl acetal) provides a more general route to the α‑heteroatom-substituted methylenedione derivatives, but, depending on the acidity-basicity matching of tricarbonylmethane derivatives and nucleophiles, a multicomponent strategy may be applied. Commonly, although less general than the DMF-DMA sequence, a Steglich-type acylation protocol proved suitable for most of the studied compounds. Taken together, these results outline a flexible and substrate-dependent approach to tricarbonylmethane derivatives, while pointing to their broader potential for constructing structurally diverse heterocyclic frameworks relevant to organic synthesis and medicinal chemistry.